Abstract:Acute respiratory distress syndrome (ARDS) is an inflammatory lung disease with a high morbidity and mortality rate, for which no pharmacologic treatment is currently available. Our previous studies discovered that a pivotal step in the disease process is the activation of the nuclear factor of activated T cells (NFAT) c3 in lung macrophages, suggesting that inhibitors against the upstream protein phosphatase calcineurin should be effective for prevention/treatment of ARDS. Herein, we report the development of a highly potent, cell-permeable, and metabolically stable peptidyl inhibitor, CNI103, which selectively blocks the interaction between calcineurin and NFATc3, through computational and medicinal chemistry. CNI103 specifically inhibited calcineurin signaling in vitro and in vivo and exhibited a favorable pharmacokinetic profile, broad tissue distribution following different routes of administration, and minimal toxicity. Our data indicate that CNI103 is a promising novel treatment for ARDS and other inflammatory diseases.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01236?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01236</a>.Table of additional acyl groups subjected to in silico screening and their calculated binding energies to calcineurin; table of sequences of hit peptides from OBOC library screening; table of stability of CNI103 upon incubation with mouse hepatocytes; tables of stability of CNI103 in simulated gastric fluid, intestinal fluid, and mouse liver microsomes; table of plasma concentration of CNI103 at different time points; structure and synthesis of OBOC peptide library; representative MALDI-TOF mass spectra of peptides derived from hit beads; representative binding curves of FITC-labeled peptides 13, 14, 16, and 19; turbidity test; effect of CN inhibitors on cell viability; effect of CNI93 on recruitment of neutrophils into lungs, on pulmonary function, on mouse body weight, and on the phosphatase activity of GST-CN toward p-nitrophenyl phosphate; CNI95 lacking ex vivo efficacy in prevention of LPS-induced cytokine production; intracellular stability of CNI103 in HCT116 cells; biodistribution of CNI103 in mice; selective uptake of CNI103Cy5 into immune cell subsets in vivo; ALI parameters in mice 24 h after LPS challenge; dose response of CNI103 for prevention of LPS-induced ALI; quantitation of TNFα levels in lung and kidney tissues of mice; and analytical HPLC tracings and MS data of peptides (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01236/suppl_file/jm0c01236_si_001.pdf">PDF</a>)Molecular formula strings of peptides (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01236/suppl_file/jm0c01236_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

A Polypeptide Inhibitor of Calcineurin Blocks the Calcineurin-Nfat Signalling Pathway in Vivo and in Vitro

A Novel Peptide Exerts Potent Immunosuppression by Blocking the Two-Site Interaction of NFAT with Calcineurin

An artificial peptide inhibits autophagy through calcineurin-TFEB pathway

Peptides Derived from Transcription Factor EB Bind to Calcineurin at a Similar Region As the NFAT-type Motif

A Peptidyl Inhibitor that Blocks Calcineurin–NFAT Interaction and Prevents Acute Lung Injury

Structure-Based Optimization of a Peptidyl Inhibitor Against Calcineurin-Nuclear Factor of Activated T Cell (NFAT) Interaction

Inhibition of Excitatory Neuronal Cell Death by Cell-Permeable Calcineurin Autoinhibitory Peptide

Inhibition of Calcineurin by Quercetin in Vitro and in Jurkat Cells.

Calcineurin inhibition by polaprezinc in rats with experimentally-induced colitis

Calcineurin Inhibitors Ameliorate PAN‐induced Podocyte Injury Through the NFAT–Angptl4 Pathway

Quercetin Targets the Interaction of Calcineurin with LxVP-type Motifs in Immunosuppression.

Effect of Different Immunosuppressive Drugs on Calcineurin and Its Mutants

Usp16-Mediated Deubiquitination Of Calcineurin A Controls Peripheral T Cell Maintenance

Microscale Thermophoresis and Fluorescence Polarization Assays of Calcineurin-Peptide Interactions

Enzymatic and thermodynamic analysis of calcineurin inhibition by RCAN1

A Peptide Derived from IKK-Interacting Protein Attenuates NF-κB Activation and Inflammation.

A peptidic network antibody inhibits both angiogenesis and inflammatory response

A PD-1 peptide antagonist exhibits potent anti-tumor and immune regulatory activity

Calcineurin B subunit interacts with proteasome subunit alpha type 7 and represses hypoxia-inducible factor-1α activity via the proteasome pathway.

Quercitrin: a New Immunosuppressant Inhibits Calcineurin*

A Novel Peptide Derived from Human Pancreatitis-Associated Protein Inhibits Inflammation in Vivo and in Vitro and Blocks NF-kappa B Signaling Pathway.